Shearwood McClelland1, Timur Mitin2, Jerry J Jaboin2, Jeremy N Ciporen3. 1. Department of Radiation Oncology, Indiana University School of Medicine, Indianapolis, Indiana, USA; Department of Radiation Medicine, Oregon Health and Science University, Portland, Oregon, USA. Electronic address: drwood@post.harvard.edu. 2. Department of Radiation Medicine, Oregon Health and Science University, Portland, Oregon, USA. 3. Department of Neurological Surgery, Oregon Health and Science University, Portland, Oregon, USA.
Abstract
BACKGROUND: Radiation therapy for central nervous system disease commonly involves collaboration between Radiation Oncology and Neurosurgery. We describe our early experience with a multidisciplinary clinic model. METHODS: In 2016, the novel RADIANS (RADIation oncology And NeuroSurgery) clinic model was initiated at a community hospital. Disease and treatment demographics were collected and analyzed. Patient satisfaction was assessed via a blinded survey questionnaire. RESULTS: Forty-two patients have been seen since the inception of RADIANS. The median age was 65; and the median patient distance from RADIANS was 42.7 miles (mean = 62.6; range = 0.7-285). Half of the patients traveled >50 miles to receive care, and >80% were seen for central nervous system metastases. Of the patients receiving radiation, 75% received stereotactic radiosurgery/stereotactic body radiation therapy. The mean overall satisfaction from 0 (not satisfied) to 5 (very satisfied) was 4.8. CONCLUSIONS: The RADIANS clinic model has proved viable and well-liked by patients in a community setting, with the majority of radiation therapy administered being stereotactic radiosurgery/stereotactic body radiation therapy rather than conventional fractionation.
BACKGROUND:Radiation therapy for central nervous system disease commonly involves collaboration between Radiation Oncology and Neurosurgery. We describe our early experience with a multidisciplinary clinic model. METHODS: In 2016, the novel RADIANS (RADIation oncology And NeuroSurgery) clinic model was initiated at a community hospital. Disease and treatment demographics were collected and analyzed. Patient satisfaction was assessed via a blinded survey questionnaire. RESULTS: Forty-two patients have been seen since the inception of RADIANS. The median age was 65; and the median patient distance from RADIANS was 42.7 miles (mean = 62.6; range = 0.7-285). Half of the patients traveled >50 miles to receive care, and >80% were seen for central nervous system metastases. Of the patients receiving radiation, 75% received stereotactic radiosurgery/stereotactic body radiation therapy. The mean overall satisfaction from 0 (not satisfied) to 5 (very satisfied) was 4.8. CONCLUSIONS: The RADIANS clinic model has proved viable and well-liked by patients in a community setting, with the majority of radiation therapy administered being stereotactic radiosurgery/stereotactic body radiation therapy rather than conventional fractionation.
Authors: Wencesley Paez; Rohi Gheewala; Shearwood McClelland; Jerry J Jaboin; Charles R Thomas; Brandon Lucke-Wold; Jeremy N Ciporen; Timur Mitin Journal: Gen Med Clin Pract Date: 2021-04-16